DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Statistics

Total Valuation

DOD Biotech PCL has a market cap or net worth of THB 779.22 million. The enterprise value is 555.05 million.

Market Cap	779.22M
Enterprise Value	555.05M

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Mar 13, 2026

Share Statistics

DOD Biotech PCL has 450.41 million shares outstanding.

Current Share Class	450.41M
Shares Outstanding	450.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.20%
Owned by Institutions (%)	19.52%
Float	261.26M

Valuation Ratios

The trailing PE ratio is 16.26.

PE Ratio	16.26
Forward PE	n/a
PS Ratio	1.25
PB Ratio	0.82
P/TBV Ratio	0.85
P/FCF Ratio	18.36
P/OCF Ratio	8.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.83, with an EV/FCF ratio of 13.08.

EV / Earnings	9.32
EV / Sales	0.89
EV / EBITDA	6.83
EV / EBIT	14.12
EV / FCF	13.08

Financial Position

The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.07.

Current Ratio	4.28
Quick Ratio	3.12
Debt / Equity	0.07
Debt / EBITDA	0.87
Debt / FCF	1.66
Interest Coverage	13.73

Financial Efficiency

Return on equity (ROE) is 5.43% and return on invested capital (ROIC) is 5.36%.

Return on Equity (ROE)	5.43%
Return on Assets (ROA)	2.01%
Return on Invested Capital (ROIC)	5.36%
Return on Capital Employed (ROCE)	3.79%
Weighted Average Cost of Capital (WACC)	8.91%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	65
Asset Turnover	0.51
Inventory Turnover	3.34

Taxes

Income Tax	-6.65M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.30% in the last 52 weeks. The beta is 0.94, so DOD Biotech PCL's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+37.30%
50-Day Moving Average	1.69
200-Day Moving Average	1.76
Relative Strength Index (RSI)	48.04
Average Volume (20 Days)	3,720,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DOD Biotech PCL had revenue of THB 621.21 million and earned 59.59 million in profits. Earnings per share was 0.13.

Revenue	621.21M
Gross Profit	222.30M
Operating Income	39.32M
Pretax Income	43.45M
Net Income	59.59M
EBITDA	80.42M
EBIT	39.32M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 290.02 million in cash and 70.35 million in debt, with a net cash position of 219.68 million or 0.49 per share.

Cash & Cash Equivalents	290.02M
Total Debt	70.35M
Net Cash	219.68M
Net Cash Per Share	0.49
Equity (Book Value)	953.84M
Book Value Per Share	2.13
Working Capital	381.14M

Cash Flow

In the last 12 months, operating cash flow was 91.31 million and capital expenditures -48.88 million, giving a free cash flow of 42.43 million.

Operating Cash Flow	91.31M
Capital Expenditures	-48.88M
Depreciation & Amortization	41.10M
Net Borrowing	24.29M
Free Cash Flow	42.43M
FCF Per Share	0.09

Margins

Gross margin is 35.78%, with operating and profit margins of 6.33% and 9.59%.

Gross Margin	35.78%
Operating Margin	6.33%
Pretax Margin	6.99%
Profit Margin	9.59%
EBITDA Margin	12.95%
EBIT Margin	6.33%
FCF Margin	6.83%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.89%.

Dividend Per Share	0.05
Dividend Yield	2.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.89%
Earnings Yield	7.65%
FCF Yield	5.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DOD Biotech PCL has an Altman Z-Score of 3.35 and a Piotroski F-Score of 7.

Altman Z-Score	3.35
Piotroski F-Score	7